Issue

Vol. 32 No. 11 (2020): Vol 32 Issue 11

Copyright (c) 2020 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Synthesis and Characterization of Mesoporous Silica Carrier Releasing Valsartan

https://doi.org/10.14233/ajchem.2020.22901
F. Muhana
Department of Pharmaceutical Science, Al-Ahliyya Amman University, Al-Salt, Jordan
R. Abu-Huwaij
Pharmacological & Diagnostic Research Center, Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Al-Ahliyya Amman University, Al-Salt, Jordan
N. Khalaf
Pharmacological & Diagnostic Research Center, Faculty of Pharmacy, Department of Pharmaceutical Sciences, Al-Ahliyya Amman University, Al-Salt, Jordan
F. Khalili
Faculty of Science, Department of Chemistry, University of Jordan, Amman, Jordan
N. Shalan
Pharmacological & Diagnostic Research Center, Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Al-Ahliyya Amman University, Al-Salt, Jordan

Corresponding Author(s) : F. Muhana

f.muhana@ammanu.edu.jo; Fhmuhana@gmail.com

Asian Journal of Chemistry, Vol. 32 No. 11 (2020): Vol 32 Issue 11

Abstract

The aim of the present study is to synthesize a mesoporous silica MCM-48 and loading it with the poorly soluble drug valsartan. The MCM-48 was characterized by Brauner-Emmett-Teller surface area analyzer, scanning electron microscope, powder X-ray diffraction, thermal gravimetric analysis and Fourier transform infra-red (FTIR). The exact loading capacity was found to be 40.12%. in vitro dissolution studies at physiological conditions demonstrated controlled release of 57.2% valsartan over 240 min. The controlled dissolution was attributed to the incomplete amorphization of crystalline valsartan by MCM-48 as evidenced by PXRD studies. The interactions between the mesoporous silica surface and drug molecules were evidenced by FTIR studies and the diffusion of therapeutic agent molecules through the silica pores. The results of the present study confirmed that the controlled adsorption and liberation of valsartan demonstrated a long-term release, which is important for its antihypertensive activity. Moreover, the structural properties of mesoporous silica assured the feasibility of designing reliable drug delivery systems by appropriate choice of the carrier.

Keywords

Mesoporous MCM-48 Mesoporous silica Valsartan Low water solubility Antihypertensive Drug delivery
Muhana, F., Abu-Huwaij, R., Khalaf, N., Khalili, F., & Shalan, N. (2020). Synthesis and Characterization of Mesoporous Silica Carrier Releasing Valsartan. Asian Journal of Chemistry, 32(11), 2927–2933. https://doi.org/10.14233/ajchem.2020.22901
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. A. Malhis, S. Arar, M. Fayyad and H. Hodali, Adsorpt. Sci. Technol., 36, 270 (2018); https://doi.org/10.1177/0263617416689270
  2. L. Zhang, S. Goh, X. Hu, R. Crawford and A. Yu, J. Chem. Technol. Biotechnol., 87, 1473 (2012); https://doi.org/10.1002/jctb.3771
  3. A. Sayari, J. Am. Chem. Soc., 122, 6504 (2000); https://doi.org/10.1021/ja0005946
  4. C. Bharti, N. Gulati, U. Nagaich and A.K. Pal, Int. J. Pharm. Investig., 5, 124 (2015); https://doi.org/10.4103/2230-973X.160844
  5. B. Zuo, W. Li, X. Wu, S. Wang, Q. Deng and M. Huang, Chem. Asian J., 15, 1248 (2020); https://doi.org/10.1002/asia.202000045
  6. C. Fruijtier-Pölloth, Toxicology, 294, 61 (2012); https://doi.org/10.1016/j.tox.2012.02.001
  7. R. Narayan, U.Y. Nayak, A.M. Raichur and S. Garg, Pharmaceutics, 10, 118 (2018); https://doi.org/10.3390/pharmaceutics10030118
  8. R. Antoninoa, M. Ruggiero, Z. Song, T.L. Nascimento, E.M. Lima, A.B. Matthias, M. Knopp and K. Löbmann, Int. J. Pharm.: X, 1, 100026 (2019); https://doi.org/10.1016/j.ijpx.2019.100026
  9. A.A. Issa and A.S. Luyt, Polymers, 11, 537 (2019); https://doi.org/10.3390/polym11030537
  10. D. Arcos and M. Vallet-Regí, Acta Mater., 61, 890 (2013); https://doi.org/10.1016/j.actamat.2012.10.039
  11. M.-S. Kim and I.-H. Baek, Int. J. Nanomed., 9, 5167 (2014); https://doi.org/10.2147/IJN.S71891
  12. I. Izquierdo-Barba, F. Martinez, D. Doadrio, J. P’erez-Pariente and M. Vallet-Regi, Eur. J. Pharm. Sci., 26, 365 (2005); https://doi.org/10.1016/j.ejps.2005.06.009
  13. I. Izquierdo-Barba, E. Sousa, J.C. Doadrio, A.L. Doadrio, J.-P. Pariente, A. Martínez, F. Babonneau and M. Vallet-Regí, J. Sol-Gel Sci. Technol., 50, 421 (2009); https://doi.org/10.1007/s10971-009-1932-3
  14. Y. Wang, L. Sun, T. Jiang, J. Zhang, C. Zhang, C. Sun, Y. Deng, J. Sun and S. Wang, Drug Dev. Ind. Pharm., 40, 819 (2014); https://doi.org/10.3109/03639045.2013.788013
  15. J. Zhang, F. Yuan, Y. Wang, H. Chen, F. Luo, X. Cheng, R.-X. Zhuo and X.-Z. Zhang, J. Am. Chem. Soc., 135, 5068 (2013); https://doi.org/10.1021/ja312004m
  16. V. Mamaeva, M. Rosenholm, T. Bate-Eya, L. Bergman, E. Peuhu, A. Duchanoy, L.E. Fortelius, S. Landor, D.M. Toivola, M. Lindén and C. Sahlgren, Mol. Ther., 19, 1538 (2011); https://doi.org/10.1038/mt.2011.105
  17. C.-Y. Lai, B.G. Trewyn, D.M. Jeftinija, K. Jeftinija, S. Xu, S. Jeftinija and V.S.-Y. Lin, J. Am. Chem. Soc., 125, 4451 (2003); https://doi.org/10.1021/ja028650l
  18. L. Vivero-Escoto, I. Slowing, G. Trewyn and S. Lin, Small, 6, 1952 (2010); https://doi.org/10.1002/smll.200901789
  19. M. Gary-Bobo, O. Hocine, D. Brevet, M. Maynadier, L. Raehm, S. Richeter, V. Charasson, B. Loock, A. Morère, P. Maillard, M. Garcia and J.-O. Durand, Int. J. Pharm., 423, 509 (2012); https://doi.org/10.1016/j.ijpharm.2011.11.045
  20. X. Ma, Y. Zhao, W. Ng and Y. Zhao, Chem. Eur. J., 19, 15593 (2013); https://doi.org/10.1002/chem.201302736
  21. D.W. Yeom, B.R. Chae, H.Y. Son, J.H. Kim, J.S. Chae, S.H. Song, D. Oh and Y.W. Choi, Int. J. Nanomedicine, 12, 3533 (2017); https://doi.org/10.2147/IJN.S136599
  22. T. Le, A.K.E. Elyafi, A.R. Mohammed and A. Al-Khattawi, Pharmaceutics, 11, 269 (2019); https://doi.org/10.3390%2Fpharmaceutics11060269
  23. T. Limnell, H.A. Santos, E. Mäkilä, T. Heikkilä, J. Salonen, D.Y. Murzin, N. Kumar, T. Laaksonen, L. Peltonen and J. Hirvonen, J. Pharm. Sci., 100, 3294 (2011); https://doi.org/10.1002/jps.22577
  24. N.B. Mistry, A.S. Westheim and S.E. Kjeldsen, Expert Opin. Pharmacother., 7, 575 (2006): https://doi.org/10.1517/14656566.7.5.575
  25. A. Markham and K.L. Goa, Drugs, 54, 299 (1997); https://doi.org/10.2165/00003495-199754020-00009
  26. J. Xu, J. Xie, R. Cao, L. Shi, Y. Cao, X.-Y. Zhu and J.-H. Cui, Drug Deliv., 23, 41 (2016); https://doi.org/10.3109/10717544.2014.903012
  27. N. Biswas, Eur. J. Pharm. Sci., 99, 152 (2017); https://doi.org/10.1016/j.ejps.2016.12.015
  28. R. Rajeswari, K. Abbulu, M. Sudhakar, R. Karki and B. Rajkumar, Der Pharm. Lett., 4, 1044 (2012).
  29. R. Abu-Huwaij, R. Hamed, E. Daoud and A. Alkilani, Acta Pol. Pharm.- Drug Res., 76, 313 (2019); https://doi.org/10.32383/appdr/99526
  30. B. Parmar, S. Mandal, C. Petkar, D. Patel and K. Sawant, Int. J. Pharm. Sci. Nanotech., 4, 3 (2011).
  31. R.J. Patel and Z.P. Patel, Int. J. Pharm. Sci. Nanotechnol., 6, 2077 (2013); https://doi.org/10.37285/ijpsn.2013.6.2.10
  32. S. Wang, D. Wu, Y. Sun and B. Zhong, Mater. Res. Bull., 36, 1717 (2001); https://doi.org/10.1016/S0025-5408(01)00645-6
  33. G. Bhattacharyya, G. Lelong and M.-L. Saboungi, J. Exp. Nanosci., 1, 375 (2016); https://doi.org/10.1080/17458080600812757
  34. K. Schumacher, P.I. Ravikovitch, A. Du Chesne, A.V. Neimark and K.K. Unger, Langmuir, 16, 4648 (2000); https://doi.org/10.1021/la991595i
  35. M. Skotnicki, P. Cebe and A. Gawel and M. Pyda, Drug Dev. Ind. Pharm., 39, 1508 (2012); https://doi.org/10.3109/03639045.2012.704379
  36. R. Schmidt, M. Stöcker, D. Akporiaye, E.H. Tørstad and A. Olsen, Micropor. Mater., 5, 1 (1995); https://doi.org/10.1016/0927-6513(95)00030-D
  37. W. Xu, H. Xie, Q. Cao, L. Shi, Y. Cao, X.-Y. Zhu and J.-H. Cui, Drug Deliv., 23, 41 (2016); https://doi.org/10.3109/10717544.2014.903012
  38. S. Wu, F. Li, R. Xu, S. Wei and G. Li, J. Nanopart. Res., 12, 2111 (2010); https://doi.org/10.1007/s11051-009-9770-3
  39. A. Datt, A. Burns, A. Dhuna and C. Larsen, Micropor. Mesopor. Mater., 167, 182 (2013); https://doi.org/10.1016/j.micromeso.2012.09.011
  40. K. Sing, Pure Appl. Chem., 54, 2201 (1982); https://doi.org/10.1351/pac198254112201
  41. K. Schumacher, M. Grun and K. Unger, Micropor. Mesopor. Mater., 27, 201 (1999); https://doi.org/10.1016/S1387-1811(98)00254-6
  42. K.E.A. Abou-Aitah, A.A. Farghali, A. Swiderska-Sroda, W. Lojkowski, A.F.M. Razin and M.H. Khedr, J. Nanomed. Nanotechnol., 7, 351 (2016); https://doi.org/10.4172/2157-7439.1000351
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 1 Download : 0